Chronic Critical Illness Elicits a Unique Circulating Leukocyte Transcriptome in Sepsis Survivors

Surgical sepsis has evolved into two major subpopulations: patients who rapidly recover, and those who develop chronic critical illness (CCI). Our primary aim was to determine whether CCI sepsis survivors manifest unique blood leukocyte transcriptomes in late sepsis that differ from transcriptomes among sepsis survivors with rapid recovery. In a prospective cohort study of surgical ICU patients, genome-wide expression analysis was conducted on total leukocytes in human whole blood collected on days 1 and 14 from sepsis survivors who rapidly recovered or developed CCI, defined as ICU length of stay ≥ 14 days with persistent organ dysfunction. Both sepsis patients who developed CCI and those who rapidly recovered exhibited marked changes in genome-wide expression at day 1 which remained abnormal through day 14. Although summary changes in gene expression were similar between CCI patients and subjects who rapidly recovered, CCI patients exhibited differential expression of 185 unique genes compared with rapid recovery patients at day 14 (p < 0.001). The transcriptomic patterns in sepsis survivors reveal an ongoing immune dyscrasia at the level of the blood leukocyte transcriptome, consistent with persistent inflammation and immune suppression. Furthermore, the findings highlight important genes that could compose a prognostic transcriptomic metric or serve as therapeutic targets among sepsis patients that develop CCI.

[1]  L. Moldawer,et al.  Biomarker Evidence of the Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) in Chronic Critical Illness (CCI) After Surgical Sepsis , 2021, Annals of surgery.

[2]  L. Moldawer,et al.  Dysregulated Immunity and Immunotherapy after Sepsis , 2021, Journal of clinical medicine.

[3]  B. Brumback,et al.  Older adults demonstrate biomarker evidence of the persistent inflammation, immunosuppression and catabolism syndrome (PICS) after sepsis. , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  B. Brumback,et al.  Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study , 2020, Critical Care.

[5]  B. Brumback,et al.  Prospective Validation of a Transcriptomic Metric in Severe Trauma. , 2020, Annals of surgery.

[6]  S. Anton,et al.  Current Epidemiology of Surgical Sepsis: Discordance Between Inpatient Mortality and 1-Year Outcomes. , 2019, Annals of surgery.

[7]  B. Brumback,et al.  The Development of Chronic Critical Illness Determines Physical Function, Quality of Life, and Long-Term Survival Among Early Survivors of Sepsis in Surgical ICUs* , 2019, Critical care medicine.

[8]  B. Brumback,et al.  The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients , 2018, The journal of trauma and acute care surgery.

[9]  M. Levy,et al.  Surviving sepsis campaign: research priorities for sepsis and septic shock , 2018, Intensive Care Medicine.

[10]  L. Moldawer,et al.  Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome , 2018, Front. Immunol..

[11]  Purvesh Khatri,et al.  Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters , 2018, Critical care medicine.

[12]  H. Baker,et al.  Impact of toll-like receptor 4 stimulation on human neonatal neutrophil spontaneous migration, transcriptomics, and cytokine production , 2018, Journal of Molecular Medicine.

[13]  H. Ueno,et al.  Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy , 2018, Front. Immunol..

[14]  Purvesh Khatri,et al.  A community approach to mortality prediction in sepsis via gene expression analysis , 2018, Nature Communications.

[15]  S. Khoury,et al.  Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy , 2018, Scientific Reports.

[16]  B. Brumback,et al.  Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients , 2017, The journal of trauma and acute care surgery.

[17]  Peter Nürnberg,et al.  Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[18]  B. Brumback,et al.  Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis , 2017, Shock.

[19]  B. Brumback,et al.  Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients , 2017, BMJ Open.

[20]  D. Viemann,et al.  S100-alarmin-induced innate immune programming protects newborn infants from sepsis , 2017, Nature Immunology.

[21]  L. Moldawer,et al.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome , 2017, Critical care medicine.

[22]  A. Zajac,et al.  IL-21 and T Cell Differentiation: Consider the Context. , 2016, Trends in immunology.

[23]  S. Opal,et al.  Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials* , 2016, Critical care medicine.

[24]  J. Knight,et al.  Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study , 2016, The Lancet. Respiratory medicine.

[25]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[26]  C. Georgescu,et al.  Epidemiology of severe sepsis: 2008-2012. , 2016, Journal of critical care.

[27]  H. Baker,et al.  Patterns of gene expression among murine models of hemorrhagic shock/trauma and sepsis. , 2016, Physiological genomics.

[28]  T. van der Poll,et al.  A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts , 2015, PLoS medicine.

[29]  Purvesh Khatri,et al.  A comprehensive time-course–based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set , 2015, Science Translational Medicine.

[30]  R. Hotchkiss,et al.  Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality , 2014, Shock.

[31]  D. Moore,et al.  The “Genomic Storm” Induced by Bacterial Endotoxin Is Calmed by a Nuclear Transport Modifier That Attenuates Localized and Systemic Inflammation , 2014, PloS one.

[32]  S. Lemeshow,et al.  Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study , 2014, Intensive Care Medicine.

[33]  H. Baker,et al.  Protective Immunity and Defects in the Neonatal and Elderly Immune Response to Sepsis , 2014, The Journal of Immunology.

[34]  Renda Soylemez Wiener,et al.  Two Decades of Mortality Trends Among Patients With Severe Sepsis: A Comparative Meta-Analysis* , 2014, Critical care medicine.

[35]  A. Gabrielli,et al.  Computer versus paper system for recognition and management of sepsis in surgical intensive care , 2014, The journal of trauma and acute care surgery.

[36]  D. Angus,et al.  Epidemiology of severe sepsis , 2013, Virulence.

[37]  R. Tompkins,et al.  Development of a Genomic Metric That Can Be Rapidly Used to Predict Clinical Outcome in Severely Injured Trauma Patients* , 2013, Critical care medicine.

[38]  L. Moldawer,et al.  Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.

[39]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[40]  Ronald G. Tompkins,et al.  Dissecting Inflammatory Complications in Critically Injured Patients by Within-Patient Gene Expression Changes: A Longitudinal Clinical Genomics Study , 2011, PLoS medicine.

[41]  Benjamin Tang,et al.  Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis , 2011, Critical care.

[42]  Ronald G. Tompkins,et al.  A Genomic Score Prognostic of Outcome in Trauma Patients , 2009, Molecular medicine.

[43]  Guangwu Xu,et al.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know , 2006, Cell Research.

[44]  Limin Chen,et al.  Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. , 2005, Gastroenterology.

[45]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[46]  C. Rosse,et al.  The relative importance of the bone marrow and spleen in the production and dissemination of B lymphocytes. , 1978, Cellular immunology.

[47]  Purvesh Khatri,et al.  Benchmarking Sepsis Gene Expression Diagnostics Using Public Data* , 2017, Critical care medicine.

[48]  E. Seeley,et al.  Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. , 2015, American journal of physiology. Lung cellular and molecular physiology.